Option chain shows key data for Helius Medical Tech's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Helius Medical Tech.

Helius Medical Tech (NASDAQ:HSDT) Stock, Option Chain

Helius Medical Tech

Helius Medical Technologies Inc is a neurotech company focused on neurological wellness. The company's purpose is to develop, license, or acquire non-invasive technologies targeted at reducing symptoms of neurological disease or trauma. The company's product, known as the Portable Neuromodulation Stimulator (PoNS) is authorized for sale in Canada as a class II, a non-implantable medical device intended for use as a short-term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury and is to be used in conjunction with supervised therapeutic exercise.

Display,Of,Stock,Market,Quotes

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

ACXP

BMEA

CBIO

CERO

EYEN

GOVX

GURE

HSDT

LDTC

LIMN

PHGE

PTLE

SAFX

VNCE

XAIR

Why Beyond Air Shares Are Trading Lower By Over 23%; Here Are 20 Stocks Moving Premarket

Nasdaq,Inscription,Next,To,Us,Dollars.,The,Nasdaq,Is,An

Earnings

Equities

Eurozone

Commodities

CVAC

INTS

NEHC

ORCL

TDTH

TIXT

Nasdaq Moves Higher; Oracle Shares Jump After Upbeat Q4 Results

Tallinn,,Estonia,-,August,4th,2023,-,Screen,With,Stock

Intraday Update

GNLN

HCTI

Dow Tumbles Over 100 Points; US Producer Prices Edge Higher In May

Helius Medical Technologies, Inc. - Class A Common Stock

Helius Medical Technologies Inc

Helius Medical Technologies Inc Warrants (02/02/2026)

Press Releases

General

Helius Medical Technologies, Inc. Announces the Establishment of a Wholly Owned Brain Computer Interface ("BCI") Technology Private Subsidiary

Helius Medical Technologies Announces Reverse Stock Split

Health Care

Helius Medical Technologies, Inc. Announces Reimbursement by Major Healthcare Provider for its Portable Neuromodulation Stimulator (PoNS®) Device

Helius to Spotlight Study Confirming Improved Long-Term Outcomes from Adherence to PoNS Therapy® at CMSC Annual Meeting

Helius Medical Technologies, Inc. Compliant with Nasdaq Bid Price Rule Listing Criteria

Financing

Helius Medical Technologies Announces Pricing of $9.1 Million Public Offering

Helius Medical Technologies, Inc. Announces Authorized Claim for Payment by Major Healthcare Payer for its Portable Neuromodulation Stimulator (PoNS®) Device

Small-Cap Disruptors KZIA, SNYR, HSDT, TRNR, PRSO Lead Momentum – More Microcap Stocks Inside

Positive PoNSTEP Study Results Presented at Consortium of Multiple Sclerosis Centers Annual Meeting

Helius Medical Technologies, Inc. Announces Claim Authorization by CignaHealth, for its Portable Neuromodulation Stimulator (PoNS®) Device

Comments

Helius Medical Tech

Helius Medical Tech (HSDT) Options

No option chain data available. Please try again later

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell